Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.71 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | RORC | P51449 | 10/20 | 0.53 |
| ▸ | THRA | P10827 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ESRRA | P11474 | 1/20 | 0.50 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.50 |
| ▸ | RORB | Q92753 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4817176 | 0.78 | KMT2A (0.54) | KMT2AMEN1POLB | |
| SCHEMBL27952151 | 0.76 | TACR1 (0.48) | KMT2AMEN1POLBGAA | |
| SCHEMBL2887843 | 0.76 | KMT2A (0.66) | KMT2AMEN1GAA | |
| SCHEMBL7333442 | 0.73 | KMT2A (0.56) | KMT2AMEN1 | |
| SCHEMBL6705049 | 0.72 | KMT2A (0.73) | KMT2AMEN1GAA | |
| SCHEMBL27842527 | 0.72 | KMT2A (0.54) | KMT2AMEN1POLBGAA | |
| SCHEMBL13776921 | 0.72 | KMT2A (0.63) | KMT2AMEN1GAA | |
| SCHEMBL12920653 | 0.71 | KMT2A (0.56) | KMT2AMEN1POLBGAA | |
| SCHEMBL2346146 | 0.71 | KMT2A (0.56) | KMT2AMEN1GAA | |
| SCHEMBL4816680 | 0.71 | KMT2A (0.63) | KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101495436-B | Process for the synthesis of -stilbene derivatives which makes it possible to obtain resveratrol and piceatannol | CLARIANT SPECIALTY FINE CHEM | 2014-02-26 | — | — | CN | disclosed |